Mapping research in diabetes complications; A scoping review

Fatemeh Bandarian; Shahnaz Esmaeili; Ensieh Nasli-Esfahani; Babak Arjmand; Bagher Larijani

doi:10.1007/s40200-022-01042-y

Mapping research in diabetes complications; A scoping review

J Diabetes Metab Disord. 2022 Apr 30;21(1):1171-1176. doi: 10.1007/s40200-022-01042-y. eCollection 2022 Jun.

Authors

Fatemeh Bandarian¹, Shahnaz Esmaeili², Ensieh Nasli-Esfahani³, Babak Arjmand⁴, Bagher Larijani⁵

Affiliations

¹ Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
² Evidence-Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
³ Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
⁴ Cell Therapy and Regenerative Medicine Research Center Endocrinology and Metabolism Molecular- Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
⁵ Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

Purpose: The study goal was to report research gaps in this field of diabetes complications in the past five years in Iran.

Methods: All diabetes research outputs by Iranians from Jan 2015 to Jan 2020 were retrieved by a comprehensive search in Scopus and Pubmed. After screening, remained documents were categorized into areas including complications, comorbidity, prevention, psychology, nutrition, physical activity, treatment, and gestational diabetes mellitus (GDM).

Results: 838 documents about complications were received and among the remained records, the most common topics respectively were about microvascular (44.99%), non-vascular complications (19.13%) and macrovascular (16.74%) complications. Regarding the level of evidence the most common studies were respectively animal studies (68%), case-control (57%) and randomized clinical trial (RCT) (39%).

Conclusions: The most common topics studied in Iran in the field of diabetes complication are microvascular compilations followed by non-vascular and macrovascular complications, respectively.

Keywords: Complications; Diabetes mellitus; Iran.

Publication types

Review